Regulatory Intelligence in Pharmacovigilance
As part of our ongoing regulatory intelligence activities,
QVigilance team actively monitors websites, newsletters,
and RSS feeds of regulatory authorities and international
standards organisations; as well as reviewing
relevant articles and blogs
Ongoing Monitoring Services
QVigilance continuously monitors regulatory information from local, regional and global authorities and organisations for pharmacovigilance-related regulatory intelligence to ensure that we and our customers are always up to speed and thereby maintain compliance with the latest regulatory requirements and guidelines for both investigational and authorised products.
OUR OFFER
Risk Management Services
Regulatory Update
Advice on pharmacovigilance regulations and guidance in individual countries
Case Reporting
Maintaining country-specific and regional case reporting requirements
Aggregate Reporting
Maintaining country-specific and regional periodic/aggregate reporting requirements
QPPV
Support on Local QPPV/representative/safety affiliates requirements globally
REQUEST OUR REGULATORY INTELLIGENCE SERVICES TO MANTAIN COMPLIANCE
Get in touch with our experts!

How AI is Changing Drug Safety
12 June 2026
The volume and complexity of drug safety data continue to increase across the pharmaceutical industry. Safety teams are now expected to evaluate information from spontaneous adverse event reports, clinical trials,…
Read More

What is QPPV in Pharmacovigilance?
8 May 2026
A Qualified Person Responsible for Pharmacovigilance (QPPV) is the designated individual who has overall responsibility for an organisation’s pharmacovigilance (PV) system. In practice, the role exists to ensure the marketing…
Read More

Individual Case Safety Reports (ICSRs) in Pharmacovigilance: A Practical Overview
13 March 2026
Pharmacovigilance is essential to monitor and maintain the safety of medicines throughout their lifecycle. Even after regulatory approval, new or rare adverse effects may emerge when drugs are used in…
Read More
Subscribe to our Blog!
For monthly Regulatory Intelligence insights and
pharmacovigilance updates!
